The Daily Caveat is written by Michael Thomas, a recovering corporate investigator in the Washington, DC-area.

CARE TO CONTRIBUTE?

TIPS, COMMENTS and QUESTIONS are always welcome (and strictly confidential).

Contact The Daily Caveat via:



Join our mailing list to new posts via email.



Or justrss icon read the feed...


Previous Posts Archives
3/27/2008
Biovail Quick to Settle on SEC Action
But charges still loom for company execs.

-- MDT

Labels: , ,

0 Comments.
Post a Comment
3/25/2008
Biovale Accounting Fraud Gets SEC Action
See our favorite muckracker, Gary Weiss for details. Also...a note to the folks at Reputrace - you might want to use a proxy server so that when your clients log in to review the articles from around the web you've collected for them, that it isn't, like, totally obvious who the client is and what reputational issues are of concern to them.

-- MDT

Labels: , , , ,

1 Comments.
Blogger michael webstersaid...
Michael,

Never let the watchers know that you are watching them - it discourages them.
Post a Comment
12/14/2007
Biovail Buys it sWay out of Class Action Suit
Of the U.S. suit at least, without admitting any wrongdoing and with no liability. A parallel Canadian suit is still pending, but the company claims to have that just about resolved as well.

Labels: , , ,

0 Comments.
Post a Comment
5/15/2007
Biovail Faces Expanded SEC Investigation
The SEC is coming for Canada's largest drug maker. At issue, according to the U.S. securities regulator, are Biovails string of accounting irregularities and misleading financial disclosures. Biovail acknowledged previously receiving a Wells Notice from the SEC regarding their 2003 finances. The SEC's probe now apparently extends from 2001 to 2004. Biovail founder, Eugene Melnyk, is also facing investigations into his personal conduct relating to Biovail. Additional details on the Biovail investigation can be found right here.

-- MDT

Labels: , , ,

0 Comments.
Post a Comment


all content © Michael D. Thomas 2010